Gujarat Kidney

INR
108.88
-0.06 (-0.06%)
BSENSE

Mar 05

BSE+NSE Vol: 1.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.99 lacs (-62.51%) Volume

Shareholding (Dec 2025)

FII

10.47%

Held by 9 FIIs

DII

1.67%

Held by 1 DIIs

Promoter

71.45%

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

12-Feb-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 February 2026.

The next results date for Gujarat Kidney & Super Speciality Ltd is scheduled for 14 February 2026.

View full answer

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

05-Mar-2026

As of 04-Mar, Gujarat Kidney & Super Speciality Ltd's stock is at Rs 109.10, down 0.95%, continuing a downward trend with a total decline of 3.75% over the last two days. Despite outperforming the sector today, the stock struggles below its 5-day and 20-day moving averages, indicating reduced investor interest.

As of 04-Mar, Gujarat Kidney & Super Speciality Ltd's stock price is falling, currently at Rs 109.10, down by Rs 1.05 or 0.95%. The stock has been on a downward trend, experiencing consecutive losses over the last two days, with a total decline of 3.75% during this period. Additionally, the stock touched an intraday low of Rs 106.5, reflecting a decrease of 3.31%.<BR><BR>In terms of performance relative to the sector, the Hospital & Healthcare Services sector has also seen a decline, falling by 2.1%. Furthermore, there has been a notable decrease in investor participation, with the delivery volume dropping by 50.14% compared to the 5-day average. This suggests reduced trading activity and interest in the stock.<BR><BR>Despite outperforming the sector by 1.14% today, the overall trend indicates a struggle for the stock, as it remains lower than the 5-day and 20-day moving averages, although it is higher than the 50-day, 100-day, and 200-day moving averages. Overall, these factors contribute to the stock's current decline.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 867 Cr (Micro Cap)

stock-summary
P/E

95.00

stock-summary
Industry P/E

59

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.42

stock-summary
Return on Equity

498.28%

stock-summary
Price to Book

470.48

Revenue and Profits:
Net Sales:
23 Cr
(Quarterly Results - Dec 2025)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
12.52
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.32
Tax Ratio
24.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
49.23%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
95
Industry P/E
59
Price to Book Value
471.77
EV to EBIT
68.95
EV to EBITDA
55.88
EV to Capital Employed
332.40
EV to Sales
24.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
482.06%
ROE (Latest)
498.28%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Mildly Bullish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 9 FIIs (10.47%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Craft Emerging Market Fund Pcc-citadel Capital Fund (3.89%)

Individual Investors Holdings

11.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.24% vs 13.28% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.30% vs 4.07% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.76",
          "val2": "9.64",
          "chgp": "1.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.14",
          "val2": "4.09",
          "chgp": "1.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "0.23",
          "chgp": "26.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.33",
          "val2": "2.30",
          "chgp": "1.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.42%",
          "val2": "42.43%",
          "chgp": "-0.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gujarat Kidney"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gujarat Kidney"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.17",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.45",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.11",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "43.93%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
9.76
9.64
1.24%
Operating Profit (PBDIT) excl Other Income
4.14
4.09
1.22%
Interest
0.29
0.23
26.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.33
2.30
1.30%
Operating Profit Margin (Excl OI)
42.42%
42.43%
-0.01%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.24% vs 13.28% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 1.30% vs 4.07% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Change(%)
Net Sales
35.17
NA
NA
Operating Profit (PBDIT) excl Other Income
15.45
NA
NA
Interest
0.53
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
9.11
NA
NA
Operating Profit Margin (Excl OI)
43.93%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Gujarat Kidney & Super Speciality Ltd stock-summary
stock-summary
Gujarat Kidney & Super Speciality Ltd
Micro Cap
Hospital
Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available